Clinical trial
Transcutaneous Auricular Neurostimulation (tAN) to Mitigate Withdrawal Behaviors in Neonates With Opioid Withdrawal
NCT04588519 is registered in ClinicalTrials.gov with Spark Biomedical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcutaneous Auricular Neurostimulation (tAN) to Mitigate Withdrawal Behaviors in Neonates With Opioid Withdrawal
- Lead sponsor
- Spark Biomedical, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 30, 2020
- Completion date
- December 30, 2020
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.